Supply Problems Complicate Vaccine Deal EU and J&J

0 25,235

Pharmaceutical company Johnson & Johnson has informed the EU that the vaccine maker is facing supply problems.


That could complicate plans to deliver 55 million doses of the company’s corona vaccine in the second quarter, and a concerned EU official told Reuters news agency.

The pharmaceutical company would have said that it is not impossible to achieve that goal, but it would have been reticent.

Leave A Reply